Larimar Therapeutics, Inc. — Director's Dealing 2016

Apr 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ZAFGEN, INC. (ZFGN)
CIK: 0001374690
Period of Report: 2016-03-31

Reporting Person: Allen Patricia L (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-31	Stock Option (Right to Buy)	$6.68	A	72000	Acquired	2026-03-31	Common Stock (72000)	Direct
2016-03-31	Stock Option (Right to Buy)	$6.68	A	36000	Acquired	2026-03-31	Common Stock (36000)	Direct

Footnotes

F1: 25% of this option vests on March 31, 2017, and the remainder vests in equal monthly installments thereafter over 36 months.

F2: This option vests as follows: 25% on March 31, 2017; 25% on September 30, 2017; and 50% on March 31, 2018.